Risk Factors in Progression from Endometriosis to Ovarian Cancer: a Cohort Study Based on Medical Insurance Data

Overview

Journal J Gynecol Oncol

Specialties Gynecology & Obstetrics
Oncology

Date 2018 Feb 6

PMID 29400021

Citations 11

Authors

An Jen Chiang

Chung Chang

Chi Hsiang Huang

Wei Chun Huang

Yuen Yee Kan

Jiabin Chen

Affiliations

Soon will be listed here.

Abstract

Objective: The objective was to identify risk factors that were associated with the progression from endometriosis to ovarian cancer based on medical insurance data.

Methods: The study was performed on a dataset obtained from the National Health Insurance Research Database, which covered all the inpatient claim data from 2000 to 2013 in Taiwan. The International Classification of Diseases (ICD) code 617 was used to screen the dataset for the patients who were admitted to hospital due to endometriosis. They were then tracked for subsequent diagnosis of ovarian cancer, and available biological, socioeconomic and clinical information was also collected. Univariate and multivariate analyses were then performed based on the Cox regression model to identify risk factors. C-index was calculated and cross validated.

Results: A total of 229,617 patients who were admitted to hospital due to endometriosis from 2000 to 2013 were included in the study, out of whom 1,473 developed ovarian cancer by the end of 2013. A variety of factors, including age, residence, hospital stratification, premium range, and various comorbidities had significant impact on the progression (p<0.05). Among them, age, urbanization of residence, hospital stratification, premium range, post-endometriosis childbearing, pelvic inflammation, and depression all had independent, significant impact (p<0.05). The validated C-index was 0.69.

Conclusion: For a woman diagnosed with endometriosis, increased age, residing in a highly urbanized area, low or high income, depression, pelvic inflammation, and absence of childbearing post-endometriosis all put her at high-risk to develop ovarian cancer. The findings may be of help to gynecologists to identify high-risk patients.

Citing Articles

Research progress in endometriosis-associated ovarian cancer.

Tang L, Bian C Front Oncol. 2024; 14:1381244.

PMID: 38725626 PMC: 11079782. DOI: 10.3389/fonc.2024.1381244.

Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview.

Mathur P, Bhatt S, Kumar S, Kamboj S, Kamboj R, Rana A Curr Drug Deliv. 2023; 21(9):1180-1196.

PMID: 37818568 DOI: 10.2174/0115672018253815230922070558.

Multiple types of distress are prospectively associated with increased risk of ovarian cancer.

Roberts A, Ratanatharathorn A, Chibnik L, Kubzansky L, Tworoger S Cancer Med. 2023; 12(14):15404-15413.

PMID: 37326414 PMC: 10417295. DOI: 10.1002/cam4.6125.

Diagnosis and treatment of tubal endometriosis in women undergoing laparoscopy: A case series from a single hospital.

Jiao H, Song W, Feng W, Liu H World J Clin Cases. 2022; 10(33):12136-12145.

PMID: 36483829 PMC: 9724517. DOI: 10.12998/wjcc.v10.i33.12136.

Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis.

Suszczyk D, Skiba W, Zardzewialy W, Pawlowska A, Wlodarczyk K, Polak G Int J Mol Sci. 2022; 23(19).

PMID: 36232911 PMC: 9570092. DOI: 10.3390/ijms231911607.

References

Burles K, Innes G, Senior K, Lang E, McRae A . Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware. BMC Med Res Methodol. 2017; 17(1):89. PMC: 5465555. DOI: 10.1186/s12874-017-0361-1. View

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

Gross A, Gallo J, Eaton W . Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control. 2009; 21(2):191-9. PMC: 2872112. DOI: 10.1007/s10552-009-9449-1. View

Melin A, Sparen P, Persson I, Bergqvist A . Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006; 21(5):1237-42. DOI: 10.1093/humrep/dei462. View

Giudice L, Kao L . Endometriosis. Lancet. 2004; 364(9447):1789-99. DOI: 10.1016/S0140-6736(04)17403-5. View

Penninx B, Guralnik J, Pahor M, Ferrucci L, Cerhan J, Wallace R . Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst. 1998; 90(24):1888-93. DOI: 10.1093/jnci/90.24.1888. View

Vigano P, Parazzini F, Somigliana E, Vercellini P . Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004; 18(2):177-200. DOI: 10.1016/j.bpobgyn.2004.01.007. View

OMalley K, Cook K, Price M, Wildes K, Hurdle J, Ashton C . Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005; 40(5 Pt 2):1620-39. PMC: 1361216. DOI: 10.1111/j.1475-6773.2005.00444.x. View

Svenssen Munksgaard P, Blaakaer J . The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol. 2011; 124(1):164-9. DOI: 10.1016/j.ygyno.2011.10.001. View

10.

Brinton L, Gridley G, Persson I, Baron J, Bergqvist A . Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997; 176(3):572-9. DOI: 10.1016/s0002-9378(97)70550-7. View

11.

Lin H, Tu Y, Lin S, Su W, Lin W, Lin W . Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol. 2011; 12(9):900-4. DOI: 10.1016/S1470-2045(11)70165-6. View

12.

Wang J, Wang C, Juang S, Huang K, Chou P, Chen C . Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage. Int J Cardiol. 2014; 172(1):82-7. DOI: 10.1016/j.ijcard.2013.12.082. View

13.

Kodaman P . Current strategies for endometriosis management. Obstet Gynecol Clin North Am. 2015; 42(1):87-101. DOI: 10.1016/j.ogc.2014.10.005. View

14.

Eisenberg V, Weil C, Chodick G, Shalev V . Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG. 2017; 125(1):55-62. DOI: 10.1111/1471-0528.14711. View

15.

Huang T, Poole E, Okereke O, Kubzansky L, Eliassen A, Sood A . Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies. Gynecol Oncol. 2015; 139(3):481-6. PMC: 4679423. DOI: 10.1016/j.ygyno.2015.10.004. View

16.

Vlahos N, Kalampokas T, Fotiou S . Endometriosis and ovarian cancer: a review. Gynecol Endocrinol. 2009; 26(3):213-9. DOI: 10.1080/09513590903184050. View

17.

Jayson G, Kohn E, Kitchener H, Ledermann J . Ovarian cancer. Lancet. 2014; 384(9951):1376-88. DOI: 10.1016/S0140-6736(13)62146-7. View

18.

Worley M, Welch W, Berkowitz R, Ng S . Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 2013; 14(3):5367-79. PMC: 3634491. DOI: 10.3390/ijms14035367. View

19.

Rasmussen C, Kjaer S, Albieri V, Bandera E, Doherty J, Hogdall E . Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. Am J Epidemiol. 2016; 185(1):8-20. PMC: 5209588. DOI: 10.1093/aje/kww161. View

20.

Bulun S . Endometriosis. N Engl J Med. 2009; 360(3):268-79. DOI: 10.1056/NEJMra0804690. View